Search research articles
Contact Us
Filters
Showing results (501-510 of 692) with videos related to
Page
of 70
Sort By:
International Journal of Oncology
|
July 3, 2010
Prognostic value of hTERT mRNA expression in surgical samples of lung cancer patients: the European Early Lung Cancer Project
Remco M Van den Berg, Hes Brokx, Aurélien Vesin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 19, 2005
Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer
Corneline J Hoekstra, Sigrid G Stroobants, Egbert F Smit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 9, 2012
Development of [(11)C]erlotinib positron emission tomography for in vivo evaluation of EGF receptor mutational status
Idris Bahce, Egbert F Smit, Mark Lubberink, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 29, 2010
Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients
Astrid A M van der Veldt, N Harry Hendrikse, Egbert F Smit, et al.
Clinical Lung Cancer
|
August 6, 2025
Real World Effectiveness of Durvalumab in Stage III Unresectable Non-small Cell Lung Cancer: What is the Role of PD-L1 Expression?
Hanieh Abedian Kalkhoran, Marjon V Verschueren, Bas J M Peters, et al.
Journal of Extracellular Vesicles
|
December 11, 2014
Analysis of AKT and ERK1/2 protein kinases in extracellular vesicles isolated from blood of patients with cancer
Johannes C van der Mijn, Nik Sol, Wouter Mellema, et al.
Cancer
|
October 28, 2011
Germline polymorphisms in patients with advanced nonsmall cell lung cancer receiving first-line platinum-gemcitabine chemotherapy: a prospective clinical study
Markus Joerger, Sjaak A Burgers, Paul Baas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 13, 2023
A Dysfunctional T-cell Gene Signature for Predicting Nonresponse to PD-1 Blockade in Non-small Cell Lung Cancer That Is Suitable for Routine Clinical Diagnostics
Karlijn Hummelink, Renaud Tissier, Linda J W Bosch, et al.
Neoplasia (New York, N.Y.)
|
February 22, 2005
Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis
Roderick H J Breuer, Peter J F Snijders, Egbert F Smit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 3, 2010
Outcomes of concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer and significant comorbidity
E C J Phernambucq, F O B Spoelstra, W F A R Verbakel, et al.
Page
of 70
Search research articles
Search
Showing results (501-510 of 692) with videos related to
Sort By:
Page
of 70
International Journal of Oncology
|
July 3, 2010
Prognostic value of hTERT mRNA expression in surgical samples of lung cancer patients: the European Early Lung Cancer Project
Remco M Van den Berg, Hes Brokx, Aurélien Vesin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 19, 2005
Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer
Corneline J Hoekstra, Sigrid G Stroobants, Egbert F Smit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 9, 2012
Development of [(11)C]erlotinib positron emission tomography for in vivo evaluation of EGF receptor mutational status
Idris Bahce, Egbert F Smit, Mark Lubberink, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 29, 2010
Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients
Astrid A M van der Veldt, N Harry Hendrikse, Egbert F Smit, et al.
Clinical Lung Cancer
|
August 6, 2025
Real World Effectiveness of Durvalumab in Stage III Unresectable Non-small Cell Lung Cancer: What is the Role of PD-L1 Expression?
Hanieh Abedian Kalkhoran, Marjon V Verschueren, Bas J M Peters, et al.
Journal of Extracellular Vesicles
|
December 11, 2014
Analysis of AKT and ERK1/2 protein kinases in extracellular vesicles isolated from blood of patients with cancer
Johannes C van der Mijn, Nik Sol, Wouter Mellema, et al.
Cancer
|
October 28, 2011
Germline polymorphisms in patients with advanced nonsmall cell lung cancer receiving first-line platinum-gemcitabine chemotherapy: a prospective clinical study
Markus Joerger, Sjaak A Burgers, Paul Baas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 13, 2023
A Dysfunctional T-cell Gene Signature for Predicting Nonresponse to PD-1 Blockade in Non-small Cell Lung Cancer That Is Suitable for Routine Clinical Diagnostics
Karlijn Hummelink, Renaud Tissier, Linda J W Bosch, et al.
Neoplasia (New York, N.Y.)
|
February 22, 2005
Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis
Roderick H J Breuer, Peter J F Snijders, Egbert F Smit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 3, 2010
Outcomes of concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer and significant comorbidity
E C J Phernambucq, F O B Spoelstra, W F A R Verbakel, et al.
Page
of 70